AAAAAA

   
Results: 1-9 |
Results: 9

Authors: OCONNELL MJ NAGORNEY DM BERNATH AM SCHROEDER G FITZGIBBONS RJ MAILLIARD JA BURCH P BOLTON JS COLONOTERO G KROOK JE
Citation: Mj. Oconnell et al., SEQUENTIAL INTRAHEPATIC FLUORODEOXYURIDINE AND SYSTEMIC FLUOROURACIL PLUS LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLORECTAL-CANCER CONFINED TO THE LIVER, Journal of clinical oncology, 16(7), 1998, pp. 2528-2533

Authors: BERLIN JD PROPERT KJ TRUMP D WILDING G HUDES G GLICK J BURCH P KELLER A LOEHRER P
Citation: Jd. Berlin et al., 5-FLUOROURACIL AND LEUCOVORIN THERAPY IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-II STUDY (E1889), American journal of clinical oncology, 21(2), 1998, pp. 171-176

Authors: HAYNES WJ BURCH P HALSALL R MELOTTI W NOYES G KAUSCH M KOSTKA P PITZL D
Citation: Wj. Haynes et al., THE H1 SILICON TRACKER DATA-ACQUISITION SYSTEM, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 403(2-3), 1998, pp. 313-325

Authors: RUBIN J GALANIS E BURCH P HERSH EM SPIER C AKPORIAYE E GONZALEZ R RINEHART JJ SOBOL RE SONDAK VK STAHL SM
Citation: J. Rubin et al., PHASE I II TRIAL OF THE IL-2 DNA/DMRIE/DOPE LIPID COMPLEX AS AN IMMUNOTHERAPEUTIC AGENT BY DIRECT GENE-TRANSFER IN PATIENTS WITH ADVANCED MELANOMA, RENAL-CELL CARCINOMA, AND SARCOMA/, Cancer gene therapy, 4(6), 1997, pp. 125-125

Authors: GUILLEMOT JC KRUSKAL BA ADRA CN ZHU SC KO JL BURCH P NOCKA K SEETOO K SIMONS E LIM B
Citation: Jc. Guillemot et al., TARGETED DISRUPTION OF GUANOSINE DIPHOSPHATE-DISSOCIATION INHIBITOR FOR RHO-RELATED PROTEINS, GDID4 - NORMAL HEMATOPOIETIC DIFFERENTIATION BUT SUBTLE DEFECT IN SUPEROXIDE PRODUCTION BY MACROPHAGES DERIVED FROMIN-VITRO EMBRYONAL STEM-CELL DIFFERENTIATION, Blood, 88(7), 1996, pp. 2722-2731

Authors: NOCKA KH BURCH P LEVINE BA UNDEM B SEGAL R NAIR N ALESSI MK LANDGRAF BE LOBELL R
Citation: Kh. Nocka et al., HUMAN C-KIT LIGAND ANALOG, SAF-9, WITH INCREASED GROWTH-FACTOR BUT NOT MAST-CELL STIMULATING ACTIVITY, Blood, 88(10), 1996, pp. 2180-2180

Authors: LOBELL R KO J LEVINE B LANDGRAF B NAIR N SMITH E BURCH P SEGAL R FISHER R NOCKA K
Citation: R. Lobell et al., A FORM OF C-KIT LIGAND WITH ENHANCED GROWTH-FACTOR ACTIVITY BUT NOT ENHANCED MAST-CELL DEGRANULATION ACTIVITY, Journal of allergy and clinical immunology, 95(1), 1995, pp. 292-292

Authors: NOCKA K LEVINE B NAIR N BURCH P SEGAL R ALESSI MK LANDGRAF B LOBELL R
Citation: K. Nocka et al., INCREASED ACTIVITY OF COVALENT DIMERS OF C-KIT LIGAND IN-VITRO AND IN-VIVO, Blood, 86(10), 1995, pp. 2791-2791

Authors: NOCKA KH KO JL LEVINE BA LANDGRAF BE SMITH E BURCH P GUPTA N SEGAL R LOBELL R
Citation: Kh. Nocka et al., DIMERIZATION OF C-KIT LIGAND VIA AN INTERMOLECULAR DISULFIDE BOND INCREASES ITS GROWTH-STIMULATING ACTIVITY BUT NOT ITS MAST-CELL DEGRANULATION ACTIVITY, Experimental hematology, 22(8), 1994, pp. 719-719
Risultati: 1-9 |